Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 1, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2018

Conditions
Mitochondrial Myopathies
Interventions
DIETARY_SUPPLEMENT

Niacin

The dose for a slow-released form of niacin will be 750-1000 mg/day. The daily niacin dose, 250 mg/day, is gradually escalated by 250 mg/month so that the full dose is reached after 3 months. The intervention time with the full niacin dose is 1 and 7 months for controls and patients, respectively, and subsequently total intervention time 4 and 10 months, respectively. At the end of the study, the daily dose will be decreased by 250 mg/month rate.

Sponsors
All Listed Sponsors
collaborator

Helsinki University Central Hospital

OTHER

collaborator

Institute for Molecular Medicine

OTHER

collaborator

University of Iowa

OTHER

lead

University of Helsinki

OTHER

NCT03973203 - Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients | Biotech Hunter | Biotech Hunter